Although not significant ( p = 0.09), there was a clear trend towards a correlation between calculated orientation index and tumor volume at study termination (Fig. 7g ).
← all excerpts
Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide.
1
—
—